IP Library Assignment 038139/0207
Patent Assignment
Reel/Frame 038139/0207

Assignment of Assignor's Interest

Recorded: 2016-03-30 Pages: 6
Assignor
Assignee
NOVARTIS AG
LICHTSTRASSE 35, BASEL, 4056, SWITZERLAND
Covered Properties (3)
Treatment of Cancer Using Humanized Anti-Egfrviii Chimeric Antigen Receptor
Patent: 9,394,368 →
Application: 14/184,924 →
Publication: US 2014/0322275
Anti-EGFRvIII Chimeric Antigen Receptor
Application: 61/767,071 →
TREATMENT OF CANCER USING HUMANIZED ANTI-EGFRvIII CHIMERIC ANTIGEN RECEPTOR
Related Assignments (4)
Other recorded transfers of the patents in this record — the chain of ownership.
Confirmatory License Jun 19, 2014
From: UNIVERSITY OF PENNSYLVANIA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 033200/0967 →
Assignment of Assignor's Interest Mar 30, 2016
From: OKADA, HIDEHO
To: UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION
Reel/Frame 038139/0009 →
Assignment of Assignor's Interest Mar 30, 2016
From: JOHNSON, LAURA ALEXANDRA; JUNE, CARL H.; MAUS, MARCELA; SCHOLLER, JOHN
To: THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
Reel/Frame 038139/0270 →
Assignment of Assignor's Interest Mar 30, 2016
From: BROGDON, JENNIFER; LOEW, ANDREAS
To: NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC.
Reel/Frame 038139/0104 →